Carles Arús

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Venues

NMR in biomedicine

International journal of molecular sciences

Cancers

Metabolites

Universitat Autònoma de Barcelona Facultat de Biociències

Universitat Autònoma de Barcelona Facultat de Ciències (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitat Autònoma de Barcelona Facultat de Biociències May 18 2002

Spain

Tenured Full Professor :: Biochemistry and Molecular Biology

Universitat Autònoma de Barcelona Facultat de Biociències Sep 15 1985 - May 17 2002

Spain

Tenured Assistant Professor :: Biochemistry and Molecular Biology

University of Illinois at Chicago Aug 01 1982 - Aug 30 1985

United States

Research Associate :: Biological Chemistry

Universitat Autònoma de Barcelona Facultat de Ciències Oct 01 1976 - Sep 30 1981

Spain

Laboratory teaching assistant :: Biochemistry

Education History

Universitat Autònoma de Barcelona Facultat de Ciències Jul 01 1977 - Dec 15 1981

Spain

PHD :: Biochemistry

Publications

Gülnur Ungan, Albert Pons-Escoda, Daniel Ulinic, Carles Arús, Sandra Ortega-Martorell, Ivan Olier, Alfredo Vellido, Carles Majos, Margarida Julià-Sapé
Early pseudoprogression and progression lesions in glioblastoma patients are both metabolically heterogeneous. NMR in biomedicine (2024)
Gülnur Ungan, Albert Pons-Escoda, Daniel Ulinic, Carles Arús, Sandra Ortega-Martorell, Ivan Olier, Alfredo Vellido, Carles Majos, Margarida Julià-Sapé
Early pseudoprogression and progression lesions in glioblastoma patients are both metabolically heterogeneous. NMR in biomedicine 37 (4) (2024)
Gülnur Ungan, Albert Pons-Escoda, Daniel Ulinic, Carles Arús, Sandra Ortega-Martorell, Ivan Olier, Alfredo Vellido, Carles Majos, Margarida Julià-Sapé
Early pseudoprogression and progression lesions in glioblastoma patients are both metabolically heterogeneous. NMR in biomedicine 37 (4) (2024)
Gülnur Ungan, Albert Pons-Escoda, Daniel Ulinic, Carles Arús, Alfredo Vellido, Margarida Julià-Sapé
Using Single-Voxel Magnetic Resonance Spectroscopy Data Acquired at 1.5T to Classify Multivoxel Data at 3T: A Proof-of-Concept Study. Cancers 15 (14) (2023)
Kai Zhao, Pilar Calero-Pérez, Miriam H A Bopp, Vincent Möschl, Axel Pagenstecher, Marta Mulero-Acevedo, Mario Vázquez, Carlos Barcia, Carles Arús, Christopher Nimsky, Tillmann Rusch, Jörg Walter Bartsch, Ana Paula Candiota
Correlation of MR-Based Metabolomics and Molecular Profiling in the Tumor Microenvironment of Temozolomide-Treated Orthotopic GL261 Glioblastoma in Mice. International journal of molecular sciences 24 (24) (2023)
Kai Zhao, Pilar Calero-Pérez, Miriam H A Bopp, Vincent Möschl, Axel Pagenstecher, Marta Mulero-Acevedo, Mario Vázquez, Carlos Barcia, Carles Arús, Christopher Nimsky, Tillmann Rusch, Jörg Walter Bartsch, Ana Paula Candiota
Correlation of MR-Based Metabolomics and Molecular Profiling in the Tumor Microenvironment of Temozolomide-Treated Orthotopic GL261 Glioblastoma in Mice. International journal of molecular sciences 24 (24) (2023)
Gülnur Ungan, Carles Arús, Alfredo Vellido, Margarida Julià-Sapé
A comparison of non-negative matrix underapproximation methods for the decomposition of magnetic resonance spectroscopy data from human brain tumors. NMR in biomedicine (2023)
Ana Paula Candiota, Carles Arús
Establishing Imaging Biomarkers of Host Immune System Efficacy during Glioblastoma Therapy Response: Challenges, Obstacles and Future Perspectives. Metabolites 12 (3) (2022)
Lucía Villamañan, Laura Martínez-Escardó, Carles Arús, Víctor J Yuste, Ana Paula Candiota
Successful Partnerships: Exploring the Potential of Immunogenic Signals Triggered by TMZ, CX-4945, and Combined Treatment in GL261 Glioblastoma Cells. International journal of molecular sciences 22 (7) (2021)
Pilar Calero-Pérez, Shuang Wu, Carles Arús, Ana Paula Candiota
Immune System-Related Changes in Preclinical GL261 Glioblastoma under TMZ Treatment: Explaining MRSI-Based Nosological Imaging Findings with RT-PCR Analyses. Cancers 13 (11) (2021)
Shuang Wu, Pilar Calero-Pérez, Lucia Villamañan, Nuria Arias-Ramos, Martí Pumarola, Sandra Ortega-Martorell, Margarida Julià-Sapé, Carles Arús, Ana Paula Candiota
Anti-tumour immune response in GL261 glioblastoma generated by Temozolomide Immune-Enhancing Metronomic Schedule monitored with MRSI-based nosological images. NMR in biomedicine 33 (4) (2020)
Shuang Wu, Pilar Calero-Pérez, Carles Arús, Ana Paula Candiota
Anti-PD-1 Immunotherapy in Preclinical GL261 Glioblastoma: Influence of Therapeutic Parameters and Non-Invasive Response Biomarker Assessment with MRSI-Based Approaches. International journal of molecular sciences 21 (22) (2020)
Margarida Julià-Sapé, Ana Paula Candiota, Carles Arús
Cancer metabolism in a snapshot: MRS(I). NMR in biomedicine 32 (10) (2019)
Yanisleydis Hernández-Villegas, Sandra Ortega-Martorell, Carles Arús, Alfredo Vellido, Margarida Julià-Sapé
Extraction of artefactual MRS patterns from a large database using non-negative matrix factorization. NMR in biomedicine (2019)

Carles Arús.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Carles Arús